Zobrazeno 1 - 10
of 32
pro vyhledávání: '"Anita Umerska"'
Autor:
Joakim Håkansson, Lovisa Ringstad, Anita Umerska, Jenny Johansson, Therese Andersson, Lukas Boge, René T. Rozenbaum, Prashant K. Sharma, Petter Tollbäck, Camilla Björn, Patrick Saulnier, Margit Mahlapuu
Publikováno v:
Frontiers in Cellular and Infection Microbiology, Vol 9 (2019)
Antimicrobial peptides, also known as host defense peptides, have recently emerged as a promising new category of therapeutic agents for the treatment of infectious diseases. This study evaluated the preclinical in vitro, ex vivo, and in vivo antimic
Externí odkaz:
https://doaj.org/article/a6fd761a81684aa59c942f6be65ae712
Publikováno v:
Pharmaceutics, Vol 12, Iss 4, p 368 (2020)
Ionic liquids (ILs) and deep eutectic mixtures (DEMs) are potential solutions to the problems of low solubility, polymorphism, and low bioavailability of drugs. The aim of this work was to develop and investigate ketoprofen (KET)-based ILs/DEMs conta
Externí odkaz:
https://doaj.org/article/bf276c79f5c74662a769ddba66a433c0
Autor:
Hassan Nehme, Patrick Saulnier, Alyaa A Ramadan, Viviane Cassisa, Catherine Guillet, Matthieu Eveillard, Anita Umerska
Publikováno v:
PLoS ONE, Vol 13, Iss 1, p e0189950 (2018)
Bacterial antibiotic resistance is an emerging public health problem worldwide; therefore, new therapeutic strategies are needed. Many studies have described antipsychotic compounds that present antibacterial activity. Hence, the aims of this study w
Externí odkaz:
https://doaj.org/article/5559c656e06446aeb8d8e045cf270fc6
Publikováno v:
PLoS ONE, Vol 12, Iss 8, p e0179211 (2017)
Lipid nanocapsules (LNCs) are biomimetic nanocarriers used for the encapsulation of a broad variety of active ingredients. Similar to surface active compounds, LNCs contain both hydrophilic and hydrophobic parts in their structure. Moreover, the comp
Externí odkaz:
https://doaj.org/article/3d58e4c32bcd46ada61cd04afa219027
Publikováno v:
Pharmaceutics, Vol 11, Iss 6, p 268 (2019)
Enrofloxacin (ENRO) is a poorly soluble drug used in veterinary medicine. It differs from the more widely used fluoroquinolone ciprofloxacin (CIP) by the presence of an ethyl substituent on its piperazine amino group. While a number of recent studies
Externí odkaz:
https://doaj.org/article/9e9cedd82c054a1d973db8b548ca29a6
Autor:
Anita Umerska, Magnus Strandh, Viviane Cassisa, Nada Matougui, Matthieu Eveillard, Patrick Saulnier
Publikováno v:
Biomolecules, Vol 8, Iss 4, p 122 (2018)
The worldwide occurrence of resistance to standard antibiotics and lack of new antibacterial drugs demand new strategies to treat complicated infections. Hence, the aim of this study was to examine the antibacterial activities of an antimicrobial pep
Externí odkaz:
https://doaj.org/article/1e540d3d24184a1499deb61947aad4a8
Autor:
Anita Umerska, Caroline Gaucher, Felipe Oyarzun-Ampuero, Isabelle Fries-Raeth, Florence Colin, María Gabriela Villamizar-Sarmiento, Philippe Maincent, Anne Sapin-Minet
Publikováno v:
Antioxidants, Vol 7, Iss 4, p 46 (2018)
Despite the promising biological and antioxidant properties of curcumin, its medical applications are limited due to poor solubility in water and low bioavailability. Polymeric nanoparticles (NPs) adapted to oral delivery may overcome these drawbacks
Externí odkaz:
https://doaj.org/article/4b143848f618403eb495564ea4e39440
Autor:
Yuning Zhang, Joakim Håkansson, Yanmiao Fan, Oliver C. J. Andrén, Jorge San Jacinto García, Liguo Qin, Anita Umerska, Daniel J. Hutchinson, Mads Lüchow, Margit Mahlapuu, Michael Malkoch
Publikováno v:
Macromolecular Bioscience. 23
Autor:
Anita Umerska, Marianne Parent, Lidia Tajber, Ariane Boudier, Anne Sapin-Minet, Philippe Maincent
Publikováno v:
Langmuir
Langmuir, American Chemical Society, 2020, 36 (15), pp.4165-4173. ⟨10.1021/acs.langmuir.9b03147⟩
Langmuir, American Chemical Society, 2020, 36 (15), pp.4165-4173. ⟨10.1021/acs.langmuir.9b03147⟩
International audience; Lipid nanocapsules (LNCs) are drug delivery platforms designed for different administration routes including intravenous delivery. Nanocarrier binding with plasma proteins such as albumin is an important factor that influences
Autor:
Viviane Lucia Beraldo-Araújo, Ana Flávia Siqueira Vicente, Marcelo van Vliet Lima, Anita Umerska, Eliana B. Souto, Lidia Tajber, Laura Oliveira-Nascimento
Publikováno v:
International Journal of Pharmaceutics. 626:122193
Available online 13 September 2022
The first step of a successful nanoformulation development is preformulation studies, in which the best excipients, drug-excipient compatibility and interactions can be identified. During the formulation, the c
The first step of a successful nanoformulation development is preformulation studies, in which the best excipients, drug-excipient compatibility and interactions can be identified. During the formulation, the c